Our Patrons

MR MUHAMED AL-DUBAISI
MBCHB, FRCS (Eng), FRCS (Gen. Surg)

Mr Muhamed Al-Dubaisi is a Consultant Breast Surgeon and Clinical Lead for Breast Cancer at Barnet and Chase Farm NHS Trust. He is Honorary Consultant Breast Surgeon at the Royal Free Hospital and Lead Quality Assurance Surgeon for the North London Breast Screening Unit. He is a member of the Breast Tumour Board for North London.

He specialises in the management of benign and malignant breast disease. His research interest is focused on minimising the risk of recurrence of breast cancer after treatment.

He lectures widely to general practitioners and patient groups on the importance of early diagnosis and the latest treatment techniques.

Mr. Al-Dubaisi was Rosie’s breast cancer surgeon.

PROFESSOR LOUISE JONES
BSC, MB, ChB, PhD, FRC (Path)

Professor Louise Jones is a professor of breast pathology at Barts Health NHS Trust and research group leader at Barts Cancer Institute.

Her work focuses on understanding how early breast cancer progresses, how the unique properties of a patient’s breast can influence a tumour’s behaviour, and the way those properties influence the development of tumours in the first place. She examines how medical researchers can modify these properties to prevent breast cancer.

Louise has recently initiated the Metastatic Breast Tissue Bank, which specifically aims to curate tissue samples from secondary breast cancer to help vital research into this disease.

She is also a lead of the Breast Cancer Now tissue bank which provides the cancer research community with access to human breast tissue.

She is the lead for Molecular Pathology in the 100,000 Genome Project. Louise is a passionate supporter of Patient Advocates and their role in promoting breast cancer research. She works closely with the Independent Cancer Patient Voice to ensure the research community hears patients’ concerns.

PROFESSOR DAVID MILES
MB, BS, BSc, MD, FRCP

Professor David Miles is a consultant oncologist with more than 20 years of experience in the field of breast cancer treatment and research.

He is the lead clinician for breast cancer at the Mount Vernon Cancer Centre and a module leader and lecturer at the Institute of Cancer Research. He is an adviser to the charity Breast Cancer Care, a board member of the Cancer Vaccine Institute and sits on the Central Institutional Review Board of Cancer Research UK.

David advises the National Institute for Health and Clinical Excellence (NICE) on the adoption of new drugs being considered for breast cancer. He is also the global principal investigator in clinical trials of biological therapies in the treatment of breast cancer. He serves on clinical trial steering and independent data monitoring committees for studies of novel therapies for the treatment of breast and other cancers.

He frequently travels abroad to lecture on the subject.

David looked after Rosie during her two courses of chemotherapy.

MR MARCUS ORNSTEIN
MB, ChB, FRCS

Mr Marcus Ornstein is a retired surgeon with 42 years of experience.

He is Honorary Senior Lecturer in surgery at Barts Cancer Institute, Queen Mary University of London and a retired consultant general surgeon with a continuing honorary research appointment at the Homerton University Hospital NHS Foundation Trust. Before retiring, he was the breast unit lead consultant at Homerton. He has also worked as a consultant breast surgeon at St Mary’s Hospital, London W2, now Imperial College.

Marcus has been teaching the MSc in surgical science course at Queen Mary, University of London since 2010. In addition to breast cancer, his research interests include robotic surgery and bowel complaints. He has made a DVD to increase awareness of breast cancer aimed at younger black women. Over the course of a long career he has treated patients with secondary as well as primary breast cancer.

DR PETER OSTLER
MBBS, MRCP, FRCR

Dr Peter Ostler is a Consultant Clinical Oncologist at Mount Vernon Cancer Centre and East and North Herts NHS Trust. He provides oncology input at Barnet Hospital, Royal Free London NHS Trust and Hillingdon Hospital.

Peter specialises in cancers of the breast, prostate and bladder.

For more than a decade, until 2013, he was the Clinical Lead at Mount Vernon Cancer Centre. In 2010, he led a team at the hospital in introducing the first NHS Cyberknife. He is also involved in increasing access to stereotactic radiotherapy for patients in Britain.

He has been a consultant since 1998, having completed training in oncology at several London hospitals. Peter has a particular interest in radiotherapy including hypo fractionation and brachytherapy.